CA Patent

CA2477653C — Puncturing means for use in an inhalation device

Assigned to Civitas Therapeutics Inc · Expires 2008-03-25 · 18y expired

What this patent protects

A puncturing device (1600) for puncturing of a wall, in particular the wall of a capsule containing medication for inhalation. The puncturing device or assembly comprises one or more substantially longitudinal prongs (1620), each having a puncturing surface (1630) at its distal e…

USPTO Abstract

A puncturing device (1600) for puncturing of a wall, in particular the wall of a capsule containing medication for inhalation. The puncturing device or assembly comprises one or more substantially longitudinal prongs (1620), each having a puncturing surface (1630) at its distal end as well as a primary cutting edge (1640) disposed on the periphery of the prong and terminating at the puncturing surface (1630). A substantially planar face (1650) is disposed on the periphery of each prong (1620) opposite of the primary cutting edge (1640).

Drugs covered by this patent

Patent Metadata

Patent number
CA2477653C
Jurisdiction
CA
Classification
—
Expires
2008-03-25
Drug substance claim
No
Drug product claim
No
Assignee
Civitas Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.